Skip to main content

Find Clinical Trials

Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma

NCT00220285

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Nagoya, Aichi-ken, Japan

Kashiwa-shi, Chiba, Japan

Maebashi, Gunma, Japan

Kanazawa, Ishikawa-ken, Japan

View Trial Details

Completed

Skin Biopsies in Chemotherapy-Induced Neuropathy

NCT00956033

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Erasmus MC, Centrumlocatie en Daniel den Hoed Rotterdam, South Holland, Netherlands

View Trial Details

Completed

Nutritional Assessment Intervention to Improve Cancer-Related Fatigue

NCT00507260

Conditions: Fatigue, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms

NCT00082784

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, +33 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

University of Pittsburgh Pittsburgh, Pennsylvania, United States

Medical University of South Carolina Charleston, South Carolina, United States

View Trial Details

Completed

Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma

NCT00078637

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: San Antonio, Texas, United States

View Trial Details

Completed

Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma

NCT01330173

Conditions: Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Plasma Cell Myeloma, +16 more
Locations: University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States

View Trial Details

Completed

Quality of Life in Multiple Myeloma Patients Treated With Bortezomib

NCT01021592

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

NCT00351975

Conditions: Accelerated Phase of Disease, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, +47 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

Princess Margaret Hospital Cashmere, Canterbury, New Zealand

View Trial Details

Completed

Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)

NCT01026415

Conditions: Carcinoma, Carcinomas, Disease, Hodgkin, +14 more
Locations: City of Hope Duarte, California, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

St. Francis Medical Group Oncology & Hematology Specialists Indianapolis, Indiana, United States

Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States

View Trial Details

Completed

Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma

NCT00099255

Conditions: Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +14 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of California at Los Angeles Los Angeles, California, United States

Stanford University Stanford, California, United States

Yale New Haven, Connecticut, United States

View all 13 locations

View Trial Details